Skip to content

Clinical trials

Completed Phase 4 Myelodysplastic Syndromes trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Phase: Phase 4 Status: Completed Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20052
20074
20091
20102
20132
20141
20161
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
PETHEMA Foundation2
Association pour la recherche sur les Affections Malignes en Immunologie Sanguine1
Celgene1
H. Lee Moffitt Cancer Center and Research Institute1
Hoffmann-La Roche1
King's College Hospital NHS Trust1
Memorial Sloan Kettering Cancer Center1
Novartis1
Phoenix Children's Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes17
Leukemia, Myeloid, Acute5
Iron Overload4
Anemia, Aplastic2
Hematologic Diseases2
Lymphoma2
Neoplasms2
Neoplasms, Plasma Cell2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Anemia1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.